Paragon 28 to Present at The Morgan Stanley 20th Annual Global Healthcare Conference
25 August 2022 - 10:02PM
Business Wire
Paragon 28, Inc. (NYSE: FNA), a leading medical device company
exclusively focused on the foot and ankle orthopedic market,
announced today that Albert DaCosta, Chairman and CEO, and Steve
Deitsch, CFO, will be presenting at the Morgan Stanley 20th Annual
Global Healthcare Conference. Mr. DaCosta and Mr. Deitsch will be
hosting a fireside chat presentation on Tuesday, September 13th,
2022, at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.
A live webcast, as well as the archived recording, will be
available on the investor relations section of the Company’s
website at ir.paragon28.com.
About Paragon 28, Inc.
Based in Englewood, Colo., Paragon 28, is a leading medical
device company exclusively focused on the foot and ankle orthopedic
market and is dedicated to improving patient lives. From the onset,
Paragon 28® has provided innovative orthopedic solutions,
procedural approaches and instrumentation that cover a wide range
of foot and ankle ailments including fracture fixation, hallux
valgus (bunions), hammertoe, ankle, progressive collapsing foot
deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The
company designs products with both the patient and surgeon in mind,
with the goal of improving outcomes, reducing ailment recurrence
and complication rates, and making the procedures simpler,
consistent, and reproducible.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220825005680/en/
Investor Contact: Gilmartin Group Matt Bacso, CFA
matt.bacso@gilmartinir.com
Paragon 28 (NYSE:FNA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Paragon 28 (NYSE:FNA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024